Professional Documents
Culture Documents
Exposure Limits Chemical and Biologic
Exposure Limits Chemical and Biologic
Updated 2007/05/25
Substance [CAS No.] Lists chemicals and other substances in alphabetical order. Numerals and prefixes, for example, 1,3-, tert-, o-, sec-, cis-, are disregarded in determining alphabetical order. In square brackets is the Chemical Abstracts Services (CAS) registry number. This is a unique identification number assigned specifically to that substance, and can be a convenient way to identify substances. If the exposure limit for a substance has been revised or newly adopted since January 1, 2003 this column reports the change with the words "Revised (year)". TWA This is the 8-hour time weighted average (TWA) limit, as defined in section 5.1 of the OHS Regulation. Units: Exposure limits are reported in ppm, mg/m3, or f/cc. In general, substances present in air as a vapour or gas are reported in parts per million (ppm). Substances present in air as an aerosol (dust, fume, mist) and mixtures such as diesel fuel are typically reported in milligrams per cubic metre (mg/m3). See OHS Guideline G5.48-4 for a procedure to convert from one type of unit to the other. Fibrous substances, such as synthetic vitreous fibres (e.g., glass wool fibres) are reported in fibres per cubic centimetre (f/cc). This is equivalent to fibres per millilitre, or f/ml, which is another common term. Endnotes: Letters in parentheses indicate endnotes, which are explained at the end of the table. Substances which have an "L" endnote are subject to section 5.57 (Designated substances) of the OHS Regulation . For more information see OHS Guideline G5.57. STEL This is the short-term exposure limit or STEL, which is defined in section 5.1 of the OHS Regulation . Note that: "C" indicates a ceiling limit, which is defined in section 5.1 of the OHS Regulation. The units ppm and mg/m3 are used as in the TWA column.
In some cases, the term "simple asphyxiant" is used. This is a gas or vapour that can displace oxygen in the air, resulting in possible suffocation from lack of oxygen. Because simple asphyxiants do not have other significant toxic effects, an exposure limit is not applicable. The limiting factor is the available oxygen. See section 5.56 of the OHS Regulation (Oxygen deficiency). Notations The notations identify substances considered to be carcinogens, sensitizers and those with adverse reproductive effect under section 5.57 of the OHS Regulation . Section 5.57 deals with requirements for substitution and keeping exposure as low as reasonably achievable below the exposure limit. The notations column also indicates substances that contribute significantly to overall exposure by the skin route, in which case section 5.52 of the OHS Regulation applies. Note that: ACGIH notations A1 and A2 and IARC notations 1, 2A and 2B indicate substances designated as carcinogens under section 5.57(1) of the OHS Regulation . The different categories used by the two organizations indicate different levels of certainty of carcinogenic effect, eg. from confirmed carcinogen to probable or possible. For more information see OHS Guideline G5.57. The letter " S" indicates that the substance is a sensitizer under section 5.57(1) of the OHS Regulation . For more information see OHS Guideline G5.57. The letter " R" means that the substance has an adverse reproductive effect under section 5.57(1) of the OHS Regulation. For more information see OHS Guideline G5.57. The term "Skin" identifies substances that contribute significantly to the overall exposure by the skin route. For more information see OHS Guideline G5.52.
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 1 of 18
Updated 2007/05/25
TWA
STEL
C 25 ppm
Notations
2B 2B
Skin Skin
1.0 mg/m (V) 3 0.05mg/m (V) 1000 ppm 0.5 ppm 2 ppm 1 ppm 1 ppm 0.5 ppm 2 mg/m
3
2 ppm S S
10 mg/m 3 0.01 mg/m 3 10 mg/m (N) 20 ppm 2 ppm 0.5 mg/m 3 0.5 mg/m 0.5 mg/m 0.1 ppm (L) 0.3 mg/m
3 3 3
A2; 2B
3
Simple asphyxiant
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 2 of 18
Updated 2007/05/25
TWA
0.01 mg/m 3 0.005 ppm 0.1 f/cc (F)
STEL
Notations
A1, 1 A1, 1 2B Skin; S
Arsine [7784-42-1] Revised 2007 Asbestos - All forms [1332-21-4] Asphalt (Bitumen) fume, as benzene-soluble aerosol, Inhalable [8052- 0.5 mg/m 3 42 4] 3 Atrazine [1912-24-9] 5 mg/m Azinphos-methyl, Inhalable [86-50-0] 0.2 mg/m 3 (V) Barium and soluble compounds, as Ba [7440-39-3] Barium sulfate [7727-43-7] Benomyl [17804-35-2] Benz[a]anthracene [56-55-3] Revised 2006 Benzene [71-43-2] Benzidine [92-87-5] Benzidine based dyes Benzo[b]fluoranthene [205-99-2] Benzo[a]pyrene [50-32-8] Revised 2006 Benzotrichloride [98-07-7] Benzoyl chloride [98-88-4] Benzoyl peroxide [94-36-0] Benzyl acetate [140-11-4] Benzyl chloride [100-44-7] Beryllium and compounds, as Be [7440-41-7] Biphenyl [92-52-4] Bis(2-dimethylaminoethyl) ether (DMAEE) [3033-62-3] Bismuth telluride - Se-doped [1304-82-1] Bismuth telluride - Undoped [1304-82-1] 0.5 mg/m
3
10 mg/m 3 (N) 10 mg/m 3 (N) (L) 0.5 ppm (L) (L) (L) C 0.1 ppm C 0.5 ppm 5 mg/m 10 ppm
3
R 2.5 ppm A2, 2B Skin; A1, 1 Skin; A1, 1 2A A2, 2B A2, 1 Skin; A2, 2A 2A
C 1 ppm 0.002 mg/m 0.2 ppm 0.05 ppm 5 mg/m 3 10 mg/m 3 (N) 6 mg/m
3 3
2A A1, 1 Skin
Borate compounds, Inorganic, Inhalable [1303-96-4; 1330-43-4; 10043- 2 mg/m 3 35-3; 12179-04-3] Revised 2005 Boron oxide [1303-86-2] 10 mg/m 3 Boron tribromide [10294-33-4] Boron trifluoride [7637-07-02] Bromacil [314-40-9]
C 1 ppm C 1 ppm 10 mg/m 3 0.1 ppm 0.1 ppm 200 ppm 0.5 ppm 10 ppm 2 ppm 600 ppm 15 ppm 100 ppm 100 ppm 20 ppm 20 ppm 20 ppm 200 ppm 200 ppm 2 ppm 0.2 ppm 250 ppm Skin R A2, 2A 750 ppm C 30 ppm
Bromine [7726-95-6] Bromine pentafluoride [7789-30-2] Bromochloromethane [74-97-5] Bromoform [75-25-2] 1-Bromopropane [106-94-5] Revised 2005 1,3-Butadiene [106-99-0] n-Butane [106-97-8] n-Butanol [71-36-3] sec-Butanol [78-92-2] tert-Butanol [75-65-0] 2-Butoxyethanol (EGBE) [111-76-2] Revised 2003 2-Butoxyethyl acetate [112-07-2] Revised 2003 n-Butyl acetate [123-86-4] sec-Butyl acetate [105-46-4] tert-Butyl acetate [540-88-5] n-Butyl acrylate [141-32-2] n-Butylamine [109-73-9] Butylated hydroxytoluene (BHT), Inhalable, (2,6-Di-tert-butyl-p-cresol) 2 mg/m 3 (V) [128-37-0] tert-Butyl chromate, as CrO3 [1189-85-1]
C 5 ppm
S Skin
C 0.1 mg/m 3
Skin
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 3 of 18
Updated 2007/05/25
TWA
3 ppm 5 ppm 0.5 ppm 50 ppm 5 ppm 1 ppm 0.01 mg/m 0.01 mg/m
3 3 3
STEL
Notations
Skin; S; R R Skin A2, 1 A2, 1 A1, 1
0.002 mg/m
3
10 mg/m (N) 0.001 mg/m 0.5 mg/m 5 mg/m 3 2 mg/m 3 10 mg/m 3 (E,N) 10 mg/m 3 (N) 2 ppm 1 mg/m 5 mg/m 5 mg/m
3 3 3 3
20 mg/m
A2, 1
0.1 mg/m
3 3
0.1 mg/m (V) 3.5 mg/m 3 5000 ppm 4 ppm 25 ppm 0.1 ppm 2 ppm 2 ppm 5 ppm 10 mg/m (N) 2 mg/m 3 0.5 mg/m 3 0.5 mg/m 0.5 mg/m 0.5 ppm 0.1ppm
3 3 3
2B 15,000 ppm 12 ppm 100 ppm 0.3 ppm 5 ppm Skin; 2B Skin R Skin; A2, 2B
Skin; 2B 1 mg/m
3
Skin; 2B
1 ppm 0.3 ppm C 0.1 ppm C 1 ppm C 1 ppm Skin S Skin 2B Skin
0.3 ppm 0.05 ppm 0.05 ppm 10 ppm C 0.05 ppm 1000 ppm 500 ppm
0.15 ppm
1250 ppm
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 4 of 18
Updated 2007/05/25
TWA
1 mg/m 3 0.5 mg/m 3 2 ppm 0.001 ppm (L) 2 ppm 1000 ppm 0.1 ppm 1 ppm 1 ppm 10 ppm 0.1 ppm 50 ppm 50 ppm 1000 ppm 0.1 mg/m (V) 3 0.05 mg/m 3 0.5 mg/m 0.5 mg/m 3 0.01 mg/m 3 0.025 mg/m 3 0.025 ppm (L) 10 mg/m 3 (N) 3 0.4 mg/m 0.9 mg/m 3 0.2 mg/m 3 0.02 mg/m 0.1 mg/m 1 mg/m 3 0.2 mg/m 3 0.2 mg/m 3 (G) 0.05 mg/m 3 (V) 10 mg/m 5 mg/m 3 25 ppm 2 mg/m 3 10 ppm
3 3 3 3
STEL
Notations
Skin; 2A Skin; 2A 2B; R A1, 1 A2, 1
A1, 1 2B
0.1 mg/m 3
C 0.3 ppm 100 ppm 50 ppm 20 ppm 300 ppm 10 ppm 0.5 mg/m 75 ppm
3
50 ppm
Skin Skin
Skin
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 5 of 18
Updated 2007/05/25
TWA
600 ppm 5 mg/m 3
STEL
Notations
1 mg/m 3 0.05 ppm 0.05 mg/m 3 (V) 0.05 mg/m 3 (V) 50 ppm
2B 0.15 ppm Skin Skin Skin; S 2B 2B Skin A2 2B Skin Skin 2 ppm R Skin; 2B; R C 0.1 ppm 50 ppm 2B Skin; 2B Skin; A2 1 0.4 mg/m 3
0.01 mg/m 3 (V) 0.2 ppm 0.1 ppm 0.5 ppm 0.3 ppm 1 ppm 5 mg/m 0.5 ppm
3
25 ppm 10 ppm (L) 0.005 ppm 1000 ppm 0.2 mg/m 100 ppm 200 ppm 5 ppm 10 ppm 25 ppm 2 ppm 1 ppm 10 mg/m
3 3 3
10 ppm
Skin 2B 2A Skin; 2B 2B
20 mg/m
0.05 mg/m (V) Dicyclohexylmethane-4,4'-diisocyanate [5124-30-1] (see Methylene bis (4-cyclohexyl-isocyanate)) Dicyclopentadiene [77-73-6] 5 ppm Dicyclopentadienyl iron [102-54-5] 10 mg/m 3 (N) Dieldrin [60-57-1] 0.25 mg/m 3 Diesel fuel, as total hydrocarbons [68334-30-5; 68476-30-2; 68476-31- 100 mg/m 3 (V) 3; 68476-34-6; 77650-28-3] Diethanolamine [111-42-2] 2 mg/m 3 Diethylamine [109-89-7] 5 ppm
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 6 of 18
Updated 2007/05/25
TWA
2 ppm 1 ppm 5 mg/m 3 200 ppm 5 mg/m 3
STEL
Notations
Skin Skin; S
300 ppm 2A
100 ppm 0.01 ppm 25 ppm 0.005 ppm 5 ppm 1000 ppm 10 ppm 5 ppm 5 ppm 0.005 ppm 0.5 ppm 1000 ppm 0.5 ppm 10 ppm 0.01 ppm 5 mg/m 10 ppm
3
R C 0.01ppm Skin 2B 1250 ppm Skin; R 15 ppm 10 ppm Skin 2B Skin; A2, 2A Skin
Dinitrobenzene, all isomers [528-29-0; 99-65-0; 100-25-4; 25154-54-5] 0.15 ppm 0.2 mg/m 1 mg/m 5 mg/m 20 ppm
3 3
0.2 mg/m 3
3
150 ppm
3 3
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 7 of 18
Updated 2007/05/25
TWA
2 ppm 0.1 ppm 0.1 mg/m 1000 ppm 1000 ppm 3 ppm
3
STEL
Notations
Skin; 2A Skin
6 ppm
3
0.05 mg/m 5 ppm 5 ppm 150 ppm 5 ppm 5 ppm 10 ppm 100 ppm 5 ppm 5 ppm 50 ppm 100 ppm 0.2 ppm 50 ppm 200 ppm 10 ppm 0.5 ppm 1 ppm 10 mg/m
3
Skin Skin; R Skin; R 15 ppm 15 ppm 125 ppm 2B; S Skin 2B Skin R Skin
75 ppm
C 1 ppm
0.05 ppm 0.1 ppm 0.5 ppm 400 ppm 100 ppm
3 5 mg/m (V)
R C 5 ppm
0.05 mg/m (V) 10 mg/m 1 mg/m 3 0.5 mg/m 3 2.5 mg/m 0.1 ppm 2 ppm 0.3 ppm C 1 ppm
3 3
3 mg/m 3 S
A2, 1; S
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 8 of 18
Updated 2007/05/25
TWA
10 ppm 5 ppm 2 ppm 5 ppm 0.0003 mg/m 300 ppm 0.2 ppm 10 mg/m 3 mg/m 3 2 ppm 0.1 mg/m 3 (V)
3 4 mg/m (E) 3 3
STEL
10 ppm 10 ppm 500 ppm C 0.05 ppm
Notations
Skin Skin Skin 1 2B S
2A S
2 mg/m 3 10 mg/m 3 (N) 0.5 mg/m 3 2 ppm Simple asphyxiant 0.05 mg/m 3 0.05 mg/m 400 ppm
3
20 mg/m 3 R
Skin; 2B Skin 500 ppm Skin; 2B Skin Skin; 2B Skin Skin; R C 0.005 mg/m 3 (V) S Skin; 2B S Skin
0.002 mg/m 3 0.02 ppm 0.01 ppm 1 ppm 0.2 mg/m 0.1 ppm 0.1 ppm
3
0.005 ppm 20 ppm 200 ppm 0.5 ppm 50 ppm 50 ppm 0.01 ppm
C 0.01 ppm
0.5 ppm C 2 ppm C 2 ppm C 4.7 ppm C 5 mg/m C 2 ppm 1 ppm 0.05 ppm C10 ppm
3
Skin Skin
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 9 of 18
Updated 2007/05/25
TWA
STEL
C 2 mg/m 3
Notations
Skin; S
5 mg/m 3 0.01 ppm 1 mg/m 3 100 ppm 50 ppm 150 ppm 50 ppm 0.005 ppm 200 ppm 25 ppm 100 ppm 5 ppm 2 ppm 250 ppm
3 2 mg/m (E)
C 1 ppm (V) Skin C 5 ppm C 0.01 ppm 400 ppm 200 ppm 10 ppm Skin 310 ppm C 50 ppm Skin 1.5 ppm
3
S Skin
Lead arsenate, as Pb3(AsO4)2 [3687-31-8] Lead chromate, as Cr [7758-97-6] Lead chromate, as Pb [7758-97-6] Lindane [58-89-9] Liquified petroleum gas (L.P.G.) [68476-85-7] Lithium hydroxide [1310-65-2] Lithium hydride [7580-67-8] Magnesite [546-93-0] Revised 2006 (See Particles Not Otherwise Classified (PNOC)) Magnesium oxide (fume), Inhalable [1309-48-4] Revised 2003 Magnesium oxide, Respirable dust and fume, as Mg [1309-48-4] Malathion, Inhalable [121-75-5] Revised 2003 Maleic anhydride [108-31-6] Manganese - Elemental & inorganic compounds, as Mn [7439-96-5] Manganese cyclopentadienyl tricarbonyl, as Mn [12079-65-1] Mercury - Alkyl compounds, as Hg [7439-97-6] Mercury - Aryl compounds, as Hg [7439-97-6] Mercury - Elemental, as Hg [7439-97-6]
0.15 mg/m 3 0.012 mg/m 3 0.05 mg/m 0.5 mg/m 1000 ppm
3 3
Elemental 2B; R/Other inorganic 2A, R 2A ; R A2; 2A; R A2; 2A; R Skin 1250 ppm C 1 mg/m 3
0.025 mg/m 3
10 mg/m 3 3 mg/m 3 1 mg/m 3 (V) 0.1 ppm 0.2 mg/m 3 0.1 mg/m 3 0.01 mg/m 0.05 mg/m
3 3 3 3 3
C 0.1 mg/m
0.025 mg/m
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 10 of 18
Updated 2007/05/25
TWA
0.025 mg/m 3 0.01 mg/m 3 10 ppm 20 ppm 1000 ppm 200 ppm 2.5 mg/m
3
STEL
0.03 mg/m 25 ppm
3
Notations
Skin; R Skin
250 ppm
Skin
10 mg/m 3 0.1 ppm 0.1 ppm 2 ppm 5 mg/m 50 ppm 20 ppm 50 ppm 20 ppm
3
Skin; R Skin; R
200 ppm 1000 ppm 1000 ppm 2 ppm 1 ppm 5 ppm 50 ppm 0.5 ppm 1 ppm 50 ppm 5 ppm 50 ppm 350 ppm 0.2 ppm 400 ppm 50 ppm 50 ppm 0.2 mg/m
3
250 ppm 1250 ppm Skin; S Skin 15 ppm Skin Skin R Skin Skin; R
75 ppm
0.05 mg/m 3 (V) 0.005 ppm C 0.01 ppm 0.01 ppm 0.005 ppm 0.01 ppm 50 ppm 100 ppm 0.01 ppm 2 ppm 50 ppm 25 ppm 50 ppm C 0.01 ppm
Skin; 2B 100 ppm C 0.2 ppm 150 ppm Skin Skin 40 ppm 75 ppm Skin
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 11 of 18
Updated 2007/05/25
TWA
0.02 ppm 200 ppm 0.5 ppm 50 ppm 0.5 ppm 0.5 ppm 0.2 mg/m 150 ppm 1 ppm 50 ppm
3
STEL
Notations
Skin; S
100 ppm
Skin; S Skin
Molybdenum - Metal and insoluble compounds, Respirable [7439-98-7] 3 mg/m 3 Molybdenum - Metal and insoluble compounds, Inhalable [7439-98-7] 10 mg/m 3 Molybdenum - Soluble compounds, as Mo, Respirable [7439-98-7] Monocrotophos, Inhalable [6923-22-4] Morpholine [110-91-8] Naled, Inhalable [300-76-5] Naphthalene [91-20-3] 1,5-Naphthalene diisocyanate [3173-72-6] beta-Naphthylamine [91-59-8] Natural gas [8006-14-2] Revised 2004 Natural rubber latex, as Total proteins, Inhalable [9006-04-6] Revised 2004 Neon [7440-01-9] Nickel - Insoluble inorganic compounds, as Ni [7440-02-0] Nickel - Elemental, Soluble inorganic compounds, as Ni [7440-02-0] Nickel carbonyl, as Ni [13463-39-3] Nickel subsulfide, as Ni, Inhalable [12035-72-2] Nicotine [54-11-5] Nitrapyrin [1929-82-4] Nitric acid [7697-37-2] Nitric oxide [10102-43-9] p-Nitroaniline [100-01-6] Nitrobenzene [98-95-3] p-Nitrochlorobenzene [100-00-5] 4-Nitrodiphenyl [92-93-3] Nitroethane [79-24-3] Nitrogen [7727-37-9] Nitrogen dioxide [10102-44-0] Nitrogen trifluoride [7783-54-2] Nitroglycerin (NG) [55-63-0] Nitromethane [75-52-5] 1-Nitropropane [108-03-2] 2-Nitropropane [79-46-9] 0.5 mg/m 3 0.05 mg/m 3 (V) 20 ppm 0.1 mg/m (V) 10 ppm 0.005 ppm (L) 1000 ppm 0.001 mg/m 3 Simple asphyxiant 0.05 mg/m 3 0.05 mg/m 0.001 ppm 0.1 mg/m 3 0.5 mg/m
3 3 3
10 mg/m (N) 2 ppm 25 ppm 3 mg/m 3 1 ppm 0.1 ppm (L) 100 ppm
Skin 2B 2B 2B
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 12 of 18
Updated 2007/05/25
TWA
STEL
Notations
2B 2B 2A Skin; 2A 2B 2B 2B 2B Skin
(L)
2 ppm 1 mg/m 25 ppm 200 ppm 0.1 mg/m 3 300 ppm 0.2 mg/m
3 3 3
C 0.05 ppm 0.05 ppm 0.08 ppm 0.1 ppm 0.2 ppm 2 mg/m
3
0.1 mg/m 3 0.5 mg/m 3 0.05 mg/m 3 (V) 10 mg/m (N) 0.005 ppm 0.5 mg/m 3 0.5 mg/m
3 3
Skin
100 ppm
Skin Skin
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 13 of 18
Updated 2007/05/25
TWA
0.1 mg/m 3 1 ppm 0.1 ppm 0.005 ppm 0.1 ppm
STEL
2 ppm
Notations
S Skin; 2B; S
0.05 mg/m (V) 0.1 ppm 0.3 ppm 1 ppm 1 mg/m 3 0.1 mg/m 3 0.1 ppm 0.1 ppm 1 mg/m 0.2 ppm 1 ppm 5 mg/m
3
3 mg/m
S
3
1 mg/m
20 mg/m 3 S
0.002 mg/m 3
3
40 ppm
20 ppm
3
0.1 mg/m
0.3 mg/m 3
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 14 of 18
Updated 2007/05/25
TWA
0.001 mg/m 3
STEL
0.003 mg/m
3
Notations
5 mg/m 3 (V) Rosin core solder thermal decomposition products (colophony) [8050- (L) 09-7] Rotenone (commercial) [83-79-4] 5 mg/m 3 10 mg/m 3 (E,N) 400 ppm 0.1 mg/m 3 0.05 ppm 10 mg/m 3 (N)
Rouge [1309-37-1] Rubber solvent (Naphtha) [8030-30-6] Selenium and compounds, as Se [7782-49-2] Selenium hexafluoride [7783-79-1] Sesone [136-78-7]
Silica, Amorphous - Diatomaceous earth (uncalcined) Total [61790-53- 4 mg/m 3 2] Silica, Amorphous - Diatomaceous earth (uncalcined), Respirable 1.5 mg/m 3 [61790-53-2] Silica, Amorphous - Fume Total [69012-64-2] 4 mg/m 3 Silica, Amorphous - Fume, Respirable [69012-64-2] Silica, Amorphous - Precipitated and gel, Total [112926-00-8] Silica, Amorphous - Precipitated and gel, Respirable [112926-00-8] Silica, Crystalline - alpha quartz [14808-60-7; 1317-95-9] and Cristobalite, Respirable [14464-46-1] Revised 2006 Silicon [7440-21-3] Revised 2006 (See Particles Not Otherwise Classified (PNOC)) Silicon carbide Nonfibrous, Inhalable, [409-21-2] Revised 2003 Silicon carbide, Nonfibrous, Respirable, [409-21-2] Revised 2003 Silicon carbide, Fibrous (including whiskers) [409-21-2] Revised 2003 Silicon tetrahydride (Silane) [7803-62-5] Silver and Compounds (as Ag) [7440-22-4] Soapstone Soapstone, Respirable Sodium azide (as Sodium azide) [26628-22-8] Sodium azide (as Hydrazoic acid vapour) [26628-22-8] Sodium bisulfite [7631-90-5] Sodium fluoroacetate [62-74-8] Sodium hydroxide [1310-73-2] Sodium metabisulfite [7681-57-4] Starch [9005-25-8] Stearates Stoddard solvent (mineral spirits) [8052-41-3] Strontium chromate, as Cr [7789-06-2] Strychnine [57-24-9] Styrene - monomer [100-42-5] Subtilisins, as crystalline active enzyme [1395-21-7; 9014-01-1] Sucrose [57-50-1] Sulfometuron methyl [74222-97-2] Sulfotep (TEDP), Inhalable [3689-24-5] Revised 2005 Sulfur dioxide [7446-09-5] Sulfur hexafluoride [2551-62-4] 5 mg/m
3
10 mg/m 3 (E) 3 mg/m 3 (E) 0.1 f/cc (F) 0.5 ppm 0.01 mg/m
3
0.05 mg/m 3 C 2 mg/m 3 10 mg/m 3 (N) 10 mg/m 3 (J) 290 mg/m 3 0.0005 mg/m 3 0.15 mg/m 50 ppm
3
Skin
580 mg/m
10 mg/m 3 (N) 5 mg/m 3 0.1 mg/m 3 (V) 2 ppm 1000 ppm Skin 5 ppm
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 15 of 18
Updated 2007/05/25
TWA
0.2 mg/m 3 (M)
STEL
C 1ppm C 0.01 ppm C 0.1 ppm 10 ppm
Notations
A2, 1
5 ppm 1 mg/m 3 1 f/cc (F) 5 mg/m 1 f/cc (F) 1 f/cc (F) 1 f/cc (F) 1 f/cc (F) 0.2 f/cc (F) 10 mg/m 2 mg/m 3 (E) 0.1 f/cc (K) 5 mg/m
3 3 3
2B A2, 2B
A1, 1
5 mg/m 3
Tellurium and compounds (NOS), as Te, excluding hydrogen telluride 0.1 mg/m 3 [13494-80-9] Tellurium hexafluoride [7783-80-4] 0.02 ppm Temephos, Inhalable [3383-96-8] Revised 2005 1 mg/m 3 (V) 3 Terbufos, Inhalable [13071-79-9] 0.01 mg/m (V) Terepthalic acid [100-21-0] Terphenyls [26140-60-3] 1,1,2,2-Tetrabromoethane [79-27-6] Inhalable Revised 2006 1,1,1,2-Tetrachloro-2,2-difluoroethane [76-11-9] 1,1,2,2-Tetrachloro-1,2-difluoroethane [76-12-0] 1,1,2,2-Tetrachloroethane [79-34-5] Tetrachloroethylene (Perchloroethylene) [127-18-4] Tetrachloronaphthalene [1335-88-2] Tetraethyl lead, as Pb [78-00-2] Tetraethyl pyrophosphate (TEPP), Inhalable [107-49-3] Revised 2007 Tetrafluoroethylene [116-14-3] Tetrahydrofuran [109-99-9] Revised 2005 Tetramethyl lead, as Pb [75-74-1] Tetramethyl succinonitrile [3333-52-6] Tetranitromethane [509-14-8] Tetrakis (hydroxymethyl) phosphonium chloride [124-64-1] Revised 2005 Tetrakis (hydroxymethyl) phosphonium sulfate [55566-30-8] Revised 2005 [479-45-8] Tetryl Thallium and soluble compounds, as Tl [7440-28-0] 4,4' Thiobis (6-tert-butyl-m-cresol) [96-69-5] (see Cresol, all isomers) Thioglycolic acid [68-11-1] Thionyl chloride [7719-09-7] Thiram [137-26-8] Tin - Metal [7440-31-5] 0.1 ppm (V) 500 ppm 200 ppm 1 ppm 25 ppm 2 mg/m
3
10 mg/m (N)
100 ppm
0.075 mg/m 3 0.01 mg/m (V) 2 ppm 50 ppm 0.075 mg/m 3 0.5 ppm 0.005 ppm 2 mg/m
3
100 ppm
S Skin Skin
Tin - Oxide and inorganic compounds, except tin hydride, as Sn [7440- 2 mg/m 3 31-6]
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 16 of 18
Updated 2007/05/25
TWA
0.1 mg/m
3
STEL
0.2 mg/m
3
Notations
Skin 2B Skin; 2B
10 mg/m 3 (N) 20 ppm 0.005 ppm 0.005 ppm 2 ppm 2 ppm 2 ppm 0.2 ppm 1 ppm 10 ppm 10 ppm 5 mg/m 10 ppm 500 ppm 1 mg/m
3 3
C 5 ppm 25 ppm C 1000 ppm Skin A2, 2A Skin Skin; 2A 1250 ppm
3 ppm
Skin R; S
Skin Skin
0.2 mg/m 3 0.05 mg/m 50 ppm 0.2 mg/m 3 10 mg/m 3 mg/m 3 10 ppm 0.5 ppm 1 ppm 0.1 ppm
3
A1, 1 A1
C 0.05 mg/m 3
2B 2B
15 ppm
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 17 of 18
Updated 2007/05/25
TWA
0.1 ppm 1 ppm 0.05 ppm 1 ppm 500 ppm 25 ppm 350 mg/m 0.1 mg/m 3 1 mg/m 3 1 mg/m
3 3 3
STEL
Notations
Skin; 2B; R A2, 2A
75 ppm
(E) - the value is for particulate matter containing no asbestos and less than 1% crystalline silica. (F) - the value for fibres longer than 5 microns, with an aspect ratio of equal than/greater than 3:1, as determined by the membrane filter method at 400 - 450 times magnification (4 mm objective), using phase-contrast illumination. (G) - as measured by the vertical elutriator, cotton-dust sampler, see TLV Documentation. (J) - does not include stearates of toxic metals. (K) - should not exceed 2 mg/m 3 respirable particulate. (L) - exposure by all routes should be carefully controlled to levels as low as possible. (M) - refers to sulfuric acid contained in strong inorganic acid mists. Note: This OEL has been suspended. See OHS Guideline 5.48-11. (N) - the 8-hour TWA listed in the Table is for the total dust. The substance also has an 8-hour TWA of 3 mg/m 3 for the respirable fraction. (O) - sampled by method that does not collect vapour. (P) - application restricted to conditions in which there are negligible aerosol exposures. (V) - vapour and aerosol.
TWA column, bracketed letters e.g. "(L)" are end notes; STEL column C = Ceiling limit; Notations column R = Adverse reproductive effect; S = Sensitizer; A1, A2, 1, 2A, 2B = Carcinogen designations
Page 18 of 18